Published in J Clin Invest on September 01, 1942
THE RELATION OF CEPHALIN FLOCCULATION AND COLLOIDAL GOLD REACTIONS TO THE SERUM PROTEINS. J Clin Invest (1943) 7.05
Flocculation tests with electrophoretically separated serum proteins. Biochem J (1947) 5.88
Aetiological aspects of multiple sclerosis. II. Br Med J (1959) 2.31
Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol (2012) 2.15
Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest (2005) 1.95
Cerebrospinal fluid gamma-globulin in multiple sclerosis. Observations on its nature. Br Med J (1960) 1.93
Serum Proteins: A Review. J Clin Pathol (1949) 1.87
[PROTEIN-CHEMICAL AND IMMUNOLOGIC STUDIES IN PATIENTS WITH SKIN DISEASES]. Arch Klin Exp Dermatol (1965) 1.81
Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest (1990) 1.57
Multiple sclerosis and spinal-fluid gamma-globulin. Br Med J (1962) 1.46
The mechanism of active cerebral immunity to equine encephalomyelitis virus; the local antigenic booster effect of the challenge inoculum. J Exp Med (1949) 1.45
Immunoglobulins of cerebrospinal fluid in syphilis. Br J Vener Dis (1969) 1.31
A consideration of the pathogenesis of bacterial meningitis: review of experimental and clinical studies. Yale J Biol Med (1960) 1.26
Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J (1993) 1.12
Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries. Proc Natl Acad Sci U S A (1996) 1.12
Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. J Exp Med (1951) 1.10
Modern neurosyphilis--a critical analysis. West J Med (1988) 1.10
Repeated Colloidal Gold Tests in Rheumatoid Arthritis. Ann Rheum Dis (1949) 1.09
Immune studies in multiple sclerosis. Clin Exp Immunol (1966) 1.09
Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system. J Neurol Neurosurg Psychiatry (1995) 1.04
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol (2013) 1.01
Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges. Ther Adv Neurol Disord (2013) 1.01
Factors influencing the concentration gradient of protein in cerebrospinal fluid. J Clin Invest (1958) 1.00
Separation of the proteins of cerebrospinal fluid using gel electrofocusing followed by electrophoresis. J Clin Pathol (1970) 0.99
Immunoglobulin levels in the cerebrospinal fluid. Br Med J (1970) 0.97
Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest (1982) 0.96
Immunological features in multiple sclerosis. Br Med J (1976) 0.95
Spinal-fluid gamma-globulin and multiple sclerosis. Br Med J (1966) 0.95
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Rev Clin Immunol (2014) 0.94
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. BMC Cancer (2005) 0.94
Is multiple sclerosis an autoimmune disease? Autoimmune Dis (2012) 0.94
Cerebrospinal fluid in multiple sclerosis. Ann Indian Acad Neurol (2009) 0.93
The production of gamma-globulin in the central nervous system. J Neurol Neurosurg Psychiatry (1954) 0.91
Abnormalities of cerebrospinal fluid amino-acids in purulent meningitis. J Neurol Neurosurg Psychiatry (1979) 0.88
Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants. Acta Neuropathol (2015) 0.85
Abnormalities of cerebrospinal fluid amino acids in patients with the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry (1981) 0.84
Novel approaches for identifying target antigens of autoreactive human B and T cells. Semin Immunopathol (2009) 0.83
Levels of albumin, alpha-fetoprotein, and IgG in human fetal cerebrospinal fluid. Arch Dis Child (1975) 0.82
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. J Neuroinflammation (2013) 0.82
Bacteriological and serological study of chronic prostatitis patients. Br J Vener Dis (1965) 0.82
Cerebrospinal fluid analysis in clinical diagnosis. J Clin Pathol (1997) 0.82
Antibody to myelin basic protein in extracts of multiple sclerosis brain. Immunology (1981) 0.82
Agents of equine viral encephalomyelitis: correlation of serum and cerebrospinal fluid antibodies. Can J Vet Res (1988) 0.80
Expansion of CD27high plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation. Genes Immun (2013) 0.80
Plasma Transthyretin as a Biomarker of Lean Body Mass and Catabolic States. Adv Nutr (2015) 0.80
A comparative study of cerebrospinal fluid and serum proteins in multiple sclerosis with special reference to the Lange colloidal-gold reaction. Biochem J (1956) 0.79
Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis. Neurol Res Int (2011) 0.78
PROTEINS IN THE COLLOIDAL GOLD REACTION. J Clin Invest (1947) 0.78
The Ins and Outs of B Cells in Multiple Sclerosis. Front Immunol (2015) 0.78
Analysis of a predominant immunoglobulin population in the cerebrospinal fluid of a multiple sclerosis patient by means of an anti-idiotypic hybridoma antibody. Proc Natl Acad Sci U S A (1981) 0.77
A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin Exp Immunol (1981) 0.77
Antibodies in multiple sclerosis oligoclonal bands target debris. Proc Natl Acad Sci U S A (2016) 0.76
CD19 as a molecular target in CNS autoimmunity. Acta Neuropathol (2014) 0.76
Immunity mechanisms in neurological disease. Proc R Soc Med (1961) 0.75
Current research in multiple sclerosis. Postgrad Med J (1960) 0.75
Binding of 125I-labelled encephalitogenic basic protein to normal lymphocytes. Inhibition with multiple sclerosis serum. Clin Exp Immunol (1975) 0.75
Experimental malaria in man; liver function. J Clin Invest (1950) 0.75
Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study. J Neuroinflammation (2017) 0.75
High-throughput sequencing of immune repertoires in multiple sclerosis. Ann Clin Transl Neurol (2016) 0.75
AETIOLOGY of disseminated sclerosis. Br Med J (1959) 0.75
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy. J Neuroimmunol (2017) 0.75
Reviewing multiple sclerosis. Postgrad Med J (1992) 0.75
In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis. Front Immunol (2017) 0.75
FRACTIONATION OF SERUM PROTEINS IN HYPERPROTEINEMIA, WITH SPECIAL REFERENCE TO MULTIPLE MYELOMA. J Clin Invest (1941) 11.64
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
THE RELATION OF CEPHALIN FLOCCULATION AND COLLOIDAL GOLD REACTIONS TO THE SERUM PROTEINS. J Clin Invest (1943) 7.05
MECHANISM OF THE POSITIVE CEPHALIN-CHOLESTEROL FLOCCULATION REACTION IN HEPATITIS. J Clin Invest (1945) 5.81
Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst (1995) 3.96
DNA content and DNA-based centromeric index of the 24 human chromosomes. Science (1973) 3.08
Chromosome measurement and sorting by flow systems. Proc Natl Acad Sci U S A (1975) 2.37
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology (2011) 2.28
Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis. Neurology (2001) 2.27
SIGNIFICANCE OF CEPHALIN-CHOLESTEROL FLOCCULATION TEST IN MALARIAL FEVER. J Clin Invest (1945) 2.26
A prospective controlled trial of early postoperative oral intake following major abdominal gynecologic surgery. Gynecol Oncol (1997) 2.23
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (2007) 2.20
Common properties of the oncogenic RNA viruses (oncornaviruses). Virology (1970) 2.20
Search for a human breast cancer virus. Nature (1971) 2.14
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res (1996) 2.04
Mammary tumor viruses. Adv Cancer Res (1979) 2.03
Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. J Natl Cancer Inst (2000) 1.99
Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol (1994) 1.89
Murine mammary tumor virus: characterization of infection of nonmurine cells. J Virol (1976) 1.87
Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res (2000) 1.82
An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res (2000) 1.81
The relationship between maternal age and uterine dysfunction: a continuous effect throughout reproductive life. Am J Obstet Gynecol (2000) 1.72
Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res (2000) 1.67
Ultrastructural comparison of a virus from a Rhesus-monkey mammary carcinoma with four oncogenic RNA viruses. Proc Natl Acad Sci U S A (1971) 1.67
Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology (1997) 1.66
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Isolation of the mouse mammary tumor virus: chemical and morphological studies. J Natl Cancer Inst (1965) 1.51
Homology between human breast tumour RNA and mouse mammary tumour virus genome. Nature (1974) 1.51
The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. Mutat Res (1995) 1.50
Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers. Clin Cancer Res (1997) 1.48
Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses). J Virol (1971) 1.48
The fate of the ovaries after radical hysterectomy and ovarian transposition. Gynecol Oncol (1995) 1.47
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res (1998) 1.41
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.41
Neutralization of murine mammary tumour virus by sera of women with breast cancer. Nature (1971) 1.40
A VISCOUS PROTEIN OBTAINED IN LARGE AMOUNT FROM THE SERUM OF A PATIENT WITH MULTIPLE MYELOMA. J Clin Invest (1943) 1.38
Analysis of somatic cell mutations at the glycophorin A locus in atomic bomb survivors: a comparative study of assay methods. Radiat Res (1993) 1.38
Fine structure of Haemobartonella muris as compared with Eperythrozoon coccoides and Mycoplasma pulmonis. J Bacteriol (1965) 1.38
Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. Clin Cancer Res (2001) 1.37
Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol (1999) 1.35
Electron microscopy of the nucleic acid of mouse mammary tumor virus. J Virol (1970) 1.32
Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys (2000) 1.30
Detection of high-molecular-weight RNA in particles from human milk. Science (1972) 1.27
Experimental infection of a cat kidney cell line with the mouse mammary tumor virus. Cancer Res (1976) 1.27
The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67. Breast Cancer Res Treat (2000) 1.27
Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol (1999) 1.24
Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol (1995) 1.22
Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol (1999) 1.22
The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Breast Cancer Res Treat (1998) 1.21
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci (2001) 1.19
Characteristics of the structural components of the mouse mammary tumor virus. I. Morphological and biochemical studies. Virology (1971) 1.18
THE USE OF INFRA-RED FILM FOR ELECTROPHORETIC AND ULTRACENTRIFUGAL ANALYSES. Science (1941) 1.15
Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer (2001) 1.14
The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res (1998) 1.13
A study of age group track and field records to relate age and running speed. Nature (1975) 1.11
The DNA-based human karyotype. Cytometry (1984) 1.11
Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome. Oncogene (2007) 1.10
Analyses of brain tumor cell lines confirm a simple model of relationships among fluorescence in situ hybridization, DNA index, and comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.10
Reverse transcriptase and high molecular weight RNA in particles from mouse and human milk. J Natl Cancer Inst (1972) 1.10
ATTEMPTS AT PURIFICATION OF A MURINE STRAIN OF HUMAN POLIOMYELITIS VIRUS. Science (1942) 1.08
A soluble antigen of the mammary tumor virus. Virology (1967) 1.07
Phase II study of paclitaxel and valspodar (PSC 833) in refractory ovarian carcinoma: a gynecologic oncology group study. J Clin Oncol (2001) 1.07
Outcomes associated with cesarean section versus vaginal breech delivery at a university hospital. J Perinatol (2006) 1.06
Effect of cooking time and temperature on the heterocyclic amine content of fried beef patties. Food Chem Toxicol (1994) 1.05
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res (2001) 1.03
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg (1999) 1.03
Do homologous chromosomes differ? Two statistical tests. Cytogenet Cell Genet (1973) 1.03
Separation of B and C type virions by centrifugation in gentle density gradients. J Virol (1974) 1.02
Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer (1998) 1.01
Isolation and characterization of RNA-directed DNA polymerase from a B-type RNA tumor virus. J Virol (1974) 1.01
Non-specific antibody-induced suppression of the immune response. Nature (1968) 1.01
Use of the APACHE II scoring system to determine mortality of gynecologic oncology patients in the intensive care unit. Obstet Gynecol (1995) 1.00
On the frequency of chromosome exchanges in a control population measured by chromosome painting. Mutat Res (1994) 1.00
Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells. Cancer Res (1997) 1.00
A method for the continuous cultivation of mammary epithelium. In Vitro (1972) 1.00
Effect of human milk on the mouse mammary tumor virus. Cancer Res (1973) 1.00
Titrations of various mouse mammary tumor viruses in different mouse strains. J Natl Cancer Inst (1974) 0.99
Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Hum Pathol (2000) 0.99
On the possibility of a human breast cancer virus. Nature (1972) 0.98
Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus. Cancer (1975) 0.97
Stimulation of mammary tumor virus production in a mouse mammary tumor cell line. Cancer Res (1970) 0.97
Biologic characteristics of some mouse mammary tumor viruses. J Natl Cancer Inst (1976) 0.96
Inhibition of spontaneous mammary carcinoma of mice by treatment with interferon and poly I:C. Proc Soc Exp Biol Med (1971) 0.96
Discordance of risk factors for invasive and non-invasive melanoma. Lancet (1990) 0.96
Factors affecting survival after orthotopic liver transplantation in infants. Transplantation (1997) 0.96
Sperm studies in anesthesiologists. Anesthesiology (1981) 0.96
High-speed quantitative karyotyping by flow microfluorometry. Clin Chem (1975) 0.96
Melanoma surveillance and earlier diagnosis. Lancet (1987) 0.95
Some physical and biological characteristics of the mouse mammary tumor virus. Cancer Res (1973) 0.95
An established R3 mouse mammary tumor cell line; kinetics of mammary tumor virus (MTV) production. Proc Soc Exp Biol Med (1972) 0.95
In vitro susceptibility of mink lung cells to the mouse mammary tumor virus. J Natl Cancer Inst (1976) 0.95
Electron microscopy in mammary cancer research. J Natl Cancer Inst (1972) 0.94
Surface structure of mouse mammary tumor virus. Virology (1974) 0.93
Satellite DNA and cytogenetic evolution. DNA quantity, satellite DNA and karyotypic variations in kangaroo rats (genus Dipodomys). Chromosoma (1976) 0.92
Bioactivity and virions in the blood of mice with mammary tumor virus. J Natl Cancer Inst (1970) 0.92
The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer. Int J Gynecol Cancer (2006) 0.92
Breast carcinoma etiological factors. Adv Cancer Res (1983) 0.91
Evaluation of a subcutaneously implanted chamber for antibody production in rabbits. Lab Anim Sci (1992) 0.91